HIPEC for high-risk gallbladder cancer after surgery
Part of Cancer, Digestive system clinical trials.
This early-phase study tests whether a treatment called HIPEC is safe and feasible in people with high-risk gallbladder adenocarcinoma after surgery. HIPEC delivers chemotherapy directly into the abdomen during the operation to lower the chance of cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have gallbladder adenocarcinoma that was confirmed by pathology (lab testing) or cytology, and your case is considered high-risk (for example, tumor through the gallbladder wall, spilled bile during surgery, or poorly differentiated cancer).
- You must be able to do daily activities at a level doctors call ECOG 0–2 (mostly up and about).
- Your blood counts and organ tests must be within required ranges (enough hemoglobin, white blood cells, neutrophils, platelets, and acceptable liver and kidney test results).
- Your cancer must not have spread to distant sites (M0, no known metastatic disease).
- You cannot have had prior drug treatment for this cancer, and you must not be taking other investigational (study) medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called HIPEC done during/around surgery after chemotherapy for advanced stomach (gastric) cancer. It may help patients live longer or have fewer cancer-related problems after the operation.
This trial tests if adding heated chemotherapy (HIPEC) right after stomach cancer surgery can help people with locally advanced gastric cancer live longer. It's for patients whose cancer has not spread to other parts of the body and who are fit enough for major surgery.
This study looks at adding a heated medicine treatment (HIPEC with mitomycin C) during surgery to treat colon cancer that has spread to the lining of the abdomen (peritoneum). It aims to improve outcomes after surgeons remove visible tumor completely.
This trial looks at whether a heated chemotherapy treatment given in the abdomen during a planned second surgery (HIPEC) can improve outcomes for certain advanced ovarian cancers. It is for people who have already had initial chemotherapy and partially responded, with enough health to safely undergo surgery.
This Phase 3 trial studies whether adding a heated chemotherapy procedure during surgery (HIPEC) before the main cancer treatment can lower the chance that stomach cancer returns in the belly. It is for people with advanced stomach cancer who are at higher risk of cancer coming back in the peritoneum (the lining of the abdomen).
This study tests whether a specialized surgery called HIPEC (heat-treated chemotherapy placed in the belly) can improve outcomes for people with advanced stomach cancer that has reached the lining of the abdomen. It’s given after you’ve already had standard chemotherapy, aiming to better control disease in the belly.
Hear when a new Gallbladder Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.